Description General description A cocktail of four phosphatase inhibitors for broad-spectrum inhibition of both serine/threonine and protein tyrosine phosphatases. Available as a 1 ml vial or as a set of five 1 ml vials. Each vial contains 1 ml of aqueous solution with the following components: 50 mM Sodium Fluoride, 10 mM β-Glycerophosphate (Cat. No. 35675), 10 mM Sodium Pyrophosphate Decahydrate, 1 mM Sodium Orthovanadate. A cocktail of four phosphatase inhibitors for broad-spectrum inhibition of both serine/threonine and protein tyrosine phosphatases. May be used to inhibit phosphatases in cell lysates and tissue extracts. Supplied as 1 ml or as a set of five 1 ml vials. Each vial contains 1 ml of aqueous solution with the following components: Packaging 1 ml in Glass bottle 1 set in Glass bottle Biochem/physiol Actions Cell permeable: no Primary Target Serine/threonine and protein tyrosine phosphatases Product does not compete with ATP. Reversible: no Warning Toxicity: Toxic (F) Physical form In H₂O. Reconstitution For long-term storage, aliquot and freeze (-20°C). Dilute 1:5 just prior to use.